🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison of LDL-C reductions of lerodalcibep (LIB003) 300 mg to inclisira...
Status
Completed
Location
CHU de Nantes - Hôpital Nord Laennec
Start Date
2022-06-20
Trial ID
NCT05004675
Treatments Being Tested
This randomized study is to assess LDL-C reductions at Week 12 with monthly...
Status
Recruiting
Location
Beijing Anzhen Hospital of Capital Medical University
Start Date
2024-11-16
Trial ID
NCT06568471
Treatments Being Tested
This study is to assess LDL-C reductions at Week 52 with monthly (Q4W \[≤31...
Status
Unknown
Location
Sterling Research Group
Start Date
2021-04-22
Trial ID
NCT04806893
Treatments Being Tested
To assess the longer term safety, tolerability, and LDL C lowering efficacy...
Status
Completed
Location
Sterling Research Group
Start Date
2019-02-14
Trial ID
NCT03847974
Treatments Being Tested
Comparison of LDL-C reductions at Week 12 of monthly (Q4W\[≤ 31 days\]) dos...
Status
Completed
Location
Sterling Research Group
Start Date
2021-04-22
Trial ID
NCT04790513
Treatments Being Tested
To compare the pharmacokinetics (PK), and pharmacodynamics (PD) of single s...
Status
Completed
Location
Metabolic & Atherosclerosis Research Center (MARC)
Start Date
2022-01-28
Trial ID
NCT05234775
Treatments Being Tested
Study to assess the LDL-C lowering efficacy of different doses of LIB003 ad...
Status
Completed
Location
Midwest Institute For Clinical Research
Start Date
2018-05-22
Trial ID
NCT03549260
Treatments Being Tested
This study is to assess LDL-C reductions at Week 52 with monthly (Q4W \[≤31...
Status
Unknown
Location
Sterling Research Group
Start Date
2021-04-22
Trial ID
NCT04797247
Treatments Being Tested
The study is to assess the long-term safety, tolerability, and efficacy aft...
Status
Enrolling By Invitation
Location
NorthShore University Health System
Start Date
2020-12-03
Trial ID
NCT04798430
Treatments Being Tested
Randomized, double-blind, placebo-controlled, single ascending dose study i...
Status
Completed
Location
Medpace (MARC/CPU)
Start Date
2017-10-30
Trial ID
NCT03545438
Treatments Being Tested